Recent Trends and Future Prospects
Buch, Englisch, 571 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 890 g
ISBN: 978-981-19-1856-8
Verlag: Springer Nature Singapore
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Komplementäre Medizin, Asiatische Medizin (TCM), Heilpraktiker
- Naturwissenschaften Biowissenschaften Biowissenschaften
Weitere Infos & Material
Chapter 1. Quest for alternatives to antibiotics - an urgent need of the 21st century.- Chapter 2. Phytochemicals as antibacterial agents: current status and future perspective.- Chapter 3. Quorum quenching enzymes: a potent alternative to conventional antibiotics.- Chapter 4. Antibodies as antibacterial molecules: the new era of antibody-mediated immunity.- Chapter 5. Phage therapy: genomics to applications and future prospects.- Chapter 6. Alternatives to antibiotics in animal farming.- Chapter 7. Metal catalysed synthesis of b–lactam antibiotics.- Chapter 8. Upgrading the antibiotic arsenal against gram-positive bacteria: chemical modifications of vancomycin.- Chapter 9. Heterocyclic scaffolds in novel synthetic antibacterial agents.- Chapter 10. Antibacterial metal-organic frameworks.- Chapter 11. Cationic amphiphilic molecules as bactericidal agents.- Chapter 12. Polymeric nanoparticles and nanocomposites as antibacterial agents.- Chapter 13. Metallic nanoparticles and their composites as alternative antibacterial therapeutics.- Chapter 14. Carbon nanoparticles as the next generation antimicrobial agents.- Chapter 15. Dendrimeric entities as chemical alternatives towards antimicrobial therapy.- Chapter 16. Ionic liquids, ionic liquid nanoparticles and nanocomposites-the future antibiotics.- Chapter 17. Prebiotic immunomodulators to enhance mucosal immunity and to reduce mass use of antibiotics.- Chapter 18. Use of probiotics, prebiotics and synbiotics as an alternative to antibiotics.- Chapter 19. The implication of antimicrobial peptides against bacteria and their clinical aspects.- Chapter 20. development of probiotics for helocibacter pylori infection management.- Chapter 21. Implications of probiotics in management of bacterial infections.- Chapter 22. Nano carriers for the molecular targeting of pathogenic bacteria.